Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Chemokine signaling pathway | R-HSA-168638 | map04062 | fludrocortisone | 31378 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | fludrocortisone | 31378 | drug-path |
Proteasome | R-HSA-68819 | map03050 | fludrocortisone | 31378 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | fludrocortisone | 31378 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | fludrocortisone | 31378 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | milrinone | 4197 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | milrinone | 4197 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | milrinone | 4197 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | milrinone | 4197 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | milrinone | 4197 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | milrinone | 4197 | drug-path |
Asthma | R-HSA-444620 | map05310 | milrinone | 4197 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | milrinone | 4197 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | milrinone | 4197 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | milrinone | 4197 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | milrinone | 4197 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | milrinone | 4197 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | dexpropranolol | 446541 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | dexpropranolol | 446541 | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | dexpropranolol | 446541 | drug-path |